GENOMERAPID Trademark

Trademark Overview


On Thursday, September 11, 2025, a trademark application was filed for GENOMERAPID with the United States Patent and Trademark Office. The USPTO has given the GENOMERAPID trademark a serial number of 99387063. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 4, 2026. This trademark is owned by Ambry Genetics Corporation. The GENOMERAPID trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical screening; Medical testing for diagnostic or treatment purposes; DNA screening for medical purposes
genomerapid

General Information


Serial Number99387063
Word MarkGENOMERAPID
Filing DateThursday, September 11, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical screening; Medical testing for diagnostic or treatment purposes; DNA screening for medical purposes
Pseudo MarkGENOME RAPID

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 11, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmbry Genetics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656

Trademark Events


Event DateEvent Description
Thursday, September 11, 2025NEW APPLICATION ENTERED
Thursday, September 11, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, February 3, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 4, 2026ASSIGNED TO EXAMINER
Wednesday, February 4, 2026NON-FINAL ACTION WRITTEN
Wednesday, February 4, 2026NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED